newsfilter
← Latest News
Business Wire·

Virpax Pharmaceuticals Reports 2023 First Quarter Results and Recent Developments

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS)